Anest. intenziv. Med. 2017;28(2):80-84

Anaphylactic reaction to sugammadex administered at the end of surgeryAnaesthesiology - Case Reports

S. Palásková1,*, H. Paříková1, J. Vydláková2, E. Uchytilová1, E. Kieslichová1
1 Klinika anesteziologie, resuscitace a intenzivní péče, Institut klinické a experimentální medicíny Praha
2 Pracoviště laboratorních metod - ambulantní a experimentální imunologie, Institut klinické a experimentální medicíny Praha

The possibility of rapid and predictable reversal of neuromuscular blockade induced by rocuronium or vecuronium leads to more frequent use of sugammadex in clinical practice. Sugammadex seems to be a safe and well tolerated medicament, which is available throughout the European Union. We noted a case of serious anaphylactic reaction after the administration of sugammadex, manifested by cardiovascular collapse. The situation required immediate initiation of fluid and pharmacological resuscitation. With this case report we would like to illustrate that even a generally safe medicament such as sugammadex may cause serious life-threatening complications.

Keywords: sugammadex; anaphylactic reaction; perioperative complication

Received: August 9, 2016; Accepted: November 21, 2016; Published: April 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Palásková S, Paříková H, Vydláková J, Uchytilová E, Kieslichová E. Anaphylactic reaction to sugammadex administered at the end of surgery. Anest. intenziv. Med. 2017;28(2):80-84.
Download citation

References

  1. Godai, K. et al. Three cases of suspected sugammadex-induced hypersensitivity reactions. Brit. J. Anaesth., 2012, 109, 2, p. 216-218. Go to original source... Go to PubMed...
  2. Takazawa, T. et al. Three suspected cases of sugammadex-induced anaphylactic shock. BMC Anesthesiology, 2014, 14, p. 92. Go to original source... Go to PubMed...
  3. Sadleir, P. H. M. et al. Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing. Anesth. Intensive Care, 2014, 42, 1, p. 93-96. Go to original source... Go to PubMed...
  4. Jeyadoss, J. et al. Sugammadex hypersensitivity - a case of anaphylaxis. Anaesth. Intensive Care, 2014, 42, 1, p. 89-92. Go to original source... Go to PubMed...
  5. Menéndez-Ozcoidi, L. et al. Allergy to low dose sugammadex. Anaesthesia, 2011, 66, 3, p. 217-219. Go to original source... Go to PubMed...
  6. Mertes, P. M. et al. Reducing the risk of anaphylaxis during anaesthesia: 2011 updated guidelines for clinical practice. J. Investig. Allergol. Clin. Immunol., 2005, 21, 6, p. 91-101.
  7. Málek, J., Kučera, P. Systémové alergické reakce (anafylaxe) v anesteziologické praxi. Zdravotnictví a medicína [online]. [cit. 2016-03-09]. Dostupné na www: http://zdravi.e15.cz/clanek/priloha-lekarske-listy/systemove-alergicke-reakce-anafylaxe-v-anesteziologicke-praxi-452598.
  8. Savic, L. et al. Anaphylaxis associated with general anaesthesia: Challenges and recent advances. Trends in Anaesth. Crit. Care, 2012, 2, 6, p. 258-263. Go to original source...
  9. Ledford, D. K. et al. Perioperative anaphylaxis: Clinical manifestations, etiology, and diagnosis. UpToDate. [online]. [cit. 2016-03-12]. Dostupné na www: http://uptodate.com/contents/perioperative-anaphylaxis-clinical-manifestations-etiology-and-management.
  10. Adinoff, A. D. et al. Immediate skin test reactivity to Food and Drug Administration-approved standardized extracts. J. Allergy Clin. Immunol., 1990, 86, 5, p. 766-774. Go to original source... Go to PubMed...
  11. Conte, B. et al. Reversal of a rocuronium-induced grade IV anaphylaxis via early injection of a large dose of sugammadex. Canad. J. Anesth., 2014, 61, 6, p. 558-562. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.